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Background & Hypothesis:
Vasoactive hormones play an important role in the pathogenesis of preeclampsia. Investigations 
focused on the molecular genetic mechanisms of preeclampsia are limited. The present study was 
designed to investigate an association of genetic polymorphisms of vasoactive hormones with the risk 
of preeclampsia.
Methods:
A total of 459 women comprising 250 patients with a diagnosis of preeclampsia (18-44 years old) and 
209 healthy controls (18-42 years old) were recruited for the study. The following genetic 
polymorphisms of vasoactive hormones were investigated: +46G/A ADRB2, 4a/4b eNOS, K198NET- 
1. Genotyping of the gene polymorphisms were done using a real-time polymerase chain reaction with 
TaqMan probes. Statistical analysis was performed with STATISTICA for Windows 8.0.
Results:
It was found that the combinations of the 2 genetic variants such as -4b eNOS and 198N ET-1, and 
also 198N ET-1 and + 46A ADRB2 were 1.4-1.6 higher among pregnant women without preeclampsia 
(35.89% and 23.65%, respectively) than among women with preeclampsia (25.6%, Pcor = 0.04, 
14.46%, Pcor = 0.032, respectively).
Discussion & Conclusion:
The study suggests that combinations of 198N ET-1, 46A ADRB2, 4b eNOS variants exert protective 
effects against the risk of preeclampsia. The study was supported by the project (“Studying of the 
genetic risk factors for multifactorial diseases”).
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